References
- Nicholson KG. Properties of antiviral agents. 2. Lancet 1984: 2(8402): 562–4
- Dolin R, Relchman RC, Madore HR, et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982: 307(10): 580–4
- Van Voris LP, Betts RF, Hayden FG, et al. Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 1981: 245(11): 1128–31
- Wingfield WL, Pollack D, Grunert RR. Therapeutic efficacy of amantadine HC1 and rimantadine HC1 in naturally occurring influenza A2 respiratory illness in man. N Engl J Med 1969: 281(11): 579–84
- Dolin R. Antiviral chemotherapy and chemoprophylaxis. Science 1985: 227(4692): 1296–303
- Couch RB, Jackson GG. Antiviral agents in influenza: summary of Influenza Workshop VIII. J Infect Dis 1976: 134(5): 516–27
- Knight V, Gilbert BE. Chemotherapy of respiratory viruses. Adv Intern Med 1986: 31: 95–118
- Hayden FG, Hall WJ, Douglas KG Jr. Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus. J Infect Dis 1980: 141(5): 535–42
- NIH Consensus Development Conference Summary. Amantadine: does it have a role in the prevention and treatment of influenza? Ann Intern Med 1980: 92(2 Pt 1): 256–8
- Bryson YJ, Monahan C, Pollack M, et al. A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. J Infect Dis 1980: 141(5): 543–7
- Centers for Disease Control. Prevention and control of Influenza: recommendations of the Immunization Practices Advisory Committee (ADIP). MMWR 1987: 36(24): 373–87
- Hall CB. Ribavirin: beginning the blitz on respiratory viruses? Pediatr Infect Dis 1985: 4(6): 668–71
- Hall CB, Walsh EE, Hruska JF, et al. Ribavirin treatment of experimental respiratory syncytial viral infection: a controlled double-blind study in young adults. JAMA 1983: 249(19): 2666–70
- Hall CB, McBride JT, Walsh EE, et al. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection: a randomized double-blind study. N Engl J Med 1983: 308(24): 1443–7
- Taber LH, Knight V, Gilbert BE, et al. Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants. Pediatrics 1983: 72(5): 613–8
- Hall CB, McBride JT, Gala CL, et al. Ribavirin treatment of respiratory syncytial viral infection in infants with underlying cardiopulmonary disease. JAMA 1985: 254(21): 3047–51
- American Academy of Pediatrics, Committee on Infectious Diseases. Ribavirin therapy of respiratory syncytial virus. Pediatrics 1987: 79(3): 475–8
- Smith RA, Knight V, Smith JA, eds. Clinical applications of ribavirin. Oriando. FL: Academic Press, 1984
- Hall CB, Dolin R, Gala CL, et al. Children with Influenza A infection: treatment with rimantadine. Pediatrics 1987: 80(2): 275–82
- Douglas RM, Moore BW, Miles HB, et al. Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus Infections in the family setting. N Engl J Med 1986: 314(2): 65–70